Name: Venous Leg Ulcers Treatment Market - Market Analysis, Sustainable Growth Insights 2024-2031
Creator: DataM Intelligence
Published: Thu Nov 16 2023 14:58:57 GMT+0530 (India Standard Time)
License: https://www.datamintelligence.com/terms-conditions
Keywords: Venous Leg Ulcers Treatment Market

Venous Leg Ulcers Treatment Market - Market Analysis, Sustainable Growth Insights 2024-2031

Venous Leg Ulcers Treatment Market Size, Share, Growth, and Outlook (2024-2031)

<h2>Global Venous Leg Ulcers Treatment Market is segmented By Treatment Type (Compression Therapy, Advanced Wound Dressings, Debridement, Medications, Others) By Sales Channel (End User, Distribution Channel) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<h3>Market Overview</h3>

<blockquote>
The Global Venous Leg Ulcers Treatment Market reached US$ YY&nbsp;million in 2022 and is expected to reach US$ YY&nbsp;million by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
</blockquote>

Venous Leg Ulcers Treatment (VLUs) are late indicators of chronic venous insufficiency (CVI) and venous hypertension. In normal conditions, calf muscle contraction and intraluminal valves promote prograde flow while preventing blood reflux. However, when retrograde flow, obstruction, or both exist, the resultant chronic venous hypertension is responsible for the dermatologic and vascular complications that culminate in the formation of a VLU.&nbsp;

Although CVI is a well-known precipitant for VLU development, ulceration occurs rarely (5.1%) for unclear reasons. CVI may develop due to blood reflux, obstruction, or a combination of both mechanisms, causing macro- and micro-circulatory dysfunction. The increased intraluminal pressure causes protein extravasation and fibrin cuff formation, which impedes the diffusion of oxygen and growth factors, and also activates the inflammatory response.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Treatment Type, Sales Channel
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

<h3>Market Dynamics: Drivers and Restraints</h3>

Rise in technological advancements

Growing advancements in treatment therapy are anticipated to play a vital role in fueling venous leg ulcer treatment market growth during the forecast period. Traditional treatment options have been evolved into multi-component and two-layer compression therapy systems or short-stretch compression therapy systems. This has advanced the ease of bandage application for clinicians while providing them with products that deliver effective therapeutic compression and is expected to boost the market growth.

For instance, negative pressure wound therapy is one of the technologies used in venous leg ulcer treatment. Negative pressure wound therapy (NPWT) is a technology supporting the standard of care in VLUs. NPWT accelerates the healing process of venous leg ulcers with several mechanisms such as local edema reduction, reduction in bacteria, inflammatory mediators, and wound exudate.

Also, researchers at RMIT University and Bolton Clarke Research Institute have developed an AI-powered tool to screen for chronic wounds, enabling nurses to identify these hard-to-heal sores during the first assessment at a person&#39;s home. This breakthrough is significant as it allows for the identification of wounds a week earlier, a significant leap forward for the Australian health system. The tool is not sensitive to changes in ambient temperature and light, making it suitable for regular home visits and tropical environments.

Furthermore, the market is also driven by other factors like increasing adoption of compression therapy, rise in the prevalence of venous leg ulcers and others will further drive the market during the forecast period.

Market&nbsp;Restraint

The high cost of treatment is one of the major factors that hamper the market growth. For instance, according to articles published in NCBI in the USA the treatment cost of venous leg ulcers treatment is $15,732 and in the UK s &pound;7,706 per patient per annum, which translates to an annual cost of over &pound;2 billion, when extrapolated to UK population. Comparatively in USA, the treatment cost is higher due to a high number of populations, and improved healthcare infrastructure leads to higher costs.

Furthermore, lack of awareness, limited reimbursement, ageing population, complexity of wound care, regulatory challenges and others are also factors that hamper the market growth rate during the forecast period.

&nbsp;

For more details of the report&nbsp;- <a href="https://www.datamintelligence.com/download-sample/venous-leg-ulcers-treatment-market" target="_blank">Request for Sample</a>

<h2>&nbsp;</h2>

<h3>Segment Analysis</h3>

The global venous leg ulcers treatment market is segmented based on treatment type, sales channel and region.

The compression therapy segment from the treatment type segment accounted for approximately 41.7% venous leg ulcers treatment market share

The compression therapy segment from the treatment type segment accounted for approximately 41.7% and it is expected to be dominated during the forecast period. Compression therapy helps increase blood circulation in the lower legs, ankles and feet. It is an effective treatment for pain and swelling caused by conditions associated with poor circulation, such as chronic venous insufficiency and varicose veins. There are many types of compression therapy devices available over the counter or with a prescription.

For instance, in February 2021, Researchers from Tyndall National Institute at UCC; together with researchers from RCSI, University of Medicine and Health Sciences; multinationals DeRoyal Global Healthcare Solutions and Henkel launched a &euro;1 million Enterprise Ireland Innovation Partnership collaboration to innovate the next generation of compression wound care therapy.

Non-healing chronic wounds affect more than 5% of us, with numbers rising due to growing elderly and diabetic populations. These wounds cause significant morbidity and mortality, leading to &euro;12.5 billion in worldwide healthcare costs annually. In some regions of the world, a patient loses a diabetic foot to amputation every 12 seconds.

<h3>Geographical Analysis</h3>

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the novel launches, rise in prevalence of venous leg ulcer cases in the U.S and Canada, rise in R&amp;D for the development of newer products, and favourable reimbursement policies bolster the market.

For instance, in April 2022 Koya Medical stated that it commercially launched its Dayspring active compression system in the U.S. Oakland, California-based Koya designed the wearable Dayspring compression system to treat lymphedema and venous leg diseases in the lower extremities. It features a soft, breathable mesh garment with Koya&rsquo;s proprietary Flexframe &mdash; spring-like segments for delivering compression &mdash; technology.

Koya said Dayspring for the upper extremity has been commercially available since 2021. Its expansion into lower extremity care (available in both full and lower leg applications) allows the company to better support people with lymphedema and venous diseases.

<h3>COVID-19 Impact Analysis</h3>

The COVID-19 pandemic has exacerbated the challenge of treating nonhealing vascular ulcers due to lack of multidisciplinary treatment, reduced healthcare resources, and restrictions. This has led to increased morbidity and amputation rates. Training patients in self-care and triage can improve outcomes, even with telemedicine. Governments, scientific committees, and healthcare officials should focus on protecting vulnerable patients during biological storms.

<h3>Competitive Landscape</h3>

The major global players in the market include 3M, Integra Life Sciences Corporation, Smith and Nephew, Urgo Medical, Paul Hartmann, Bauerfeind Canada - Medical., Cardinal Health, Medline, Essity, Medi GmbH &amp; Co. KG and among others.

<h3>Key Developments</h3>

<ul>
	<li>In June 2023 JeNaCell, an Evonik company, launched the wound dressing epicite balance onto the German market. Available from June 2023, the dressing is particularly suited and optimized for the treatment of chronic wounds with low to medium exudation, such as venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers and soft tissue lesions.epicite balance comes in three different sizes and will be distributed through the company Coopmed ApS to hospitals and homecare centres.</li>
	<li>In January 2023, MiMedx Group, Inc. entered into an exclusive distribution agreement with GUNZE MEDICAL LIMITED for the sales of EPIFIX in Japan. EPIFIX is a PURION-processed placental tissue allograft that supports the healing cascade by providing a semi-permeable, protective barrier over wounds.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global venous leg ulcers treatment market segmentation based on treatment type, sales channel and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of venous leg ulcer treatment market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global venous leg ulcers treatment market report would provide approximately 69 tables, 58 figures and 187 Pages.

<h3>Target Audience 2023</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Treatment Type</li>
		<li>Snippet by Sales Channel</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rise in the technological advancements</li>
				<li>Rise in the prevalence of venous leg ulcers</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Restraints
		<ol>
			<li>High cost associated with the treatment</li>
		</ol>

		<ol>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Pipeline Analysis</li>
		<li>Unmet Needs</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Treatment Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Attractiveness Index, By Treatment Type</li>
		</ol>
		</li>
		<li>Compression Therapy *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		Advanced Wound Dressings
		</li>
		<li>
		Debridement
		</li>
		<li>
		Medications
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Sales Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel</li>
			<li>Market Attractiveness Index, By Sales Channel</li>
		</ol>
		</li>
		<li>End User *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Distribution Channel</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>3M *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Integra LifeSciences Corporation</li>
		<li>Smith and Nephew</li>
		<li>Urgo Medical</li>
		<li>Paul Hartmann</li>
		<li>Bauerfeind Canada - Medical.</li>
		<li>Cardinal Health</li>
		<li>Medline</li>
		<li>Essity</li>
		<li>Medi GmbH &amp; Co. KG&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2022, 2026 &amp; 2030 (US$ Million)

Table 2 Global Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2022, 2026 &amp; 2030 (US$ Million)

Table 3 Global Venous Leg Ulcers Treatment Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 4 Global Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2022, 2026 &amp; 2030 (US$ Million)

Table 5 Global Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2021-2030 (US$ Million)

Table 6 Global Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2022, 2026 &amp; 2030 (US$ Million)

Table 7 Global Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 8 Global Venous Leg Ulcers Treatment Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 9 Global Venous Leg Ulcers Treatment Market Value, By Region, 2021-2030 (US$ Million)

Table 10 North America Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2021-2030 (US$ Million)

Table 11 North America Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 12 North America Venous Leg Ulcers Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 13 South America Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2021-2030 (US$ Million)

Table 14 South America Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 15 South America Venous Leg Ulcers Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 16 Europe Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2021-2030 (US$ Million)

Table 17 Europe Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 18 Europe Venous Leg Ulcers Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 19 Asia-Pacific Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2021-2030 (US$ Million)

Table 20 Asia-Pacific Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 21 Asia-Pacific Venous Leg Ulcers Treatment Market Value, By Country, 2021-2030 (US$ Million)

Table 22 Middle East &amp; Africa Venous Leg Ulcers Treatment Market Value, By Treatment Type, 2021-2030 (US$ Million)

Table 23 Middle East &amp; Africa Venous Leg Ulcers Treatment Market Value, By Sales Channel, 2021-2030 (US$ Million)

Table 24 3M: Overview

Table 25 3M: Product Portfolio

Table 26 3M: Key Developments

Table 27 Integra LifeSciences Corporation: Overview

Table 28 Integra LifeSciences Corporation: Product Portfolio

Table 29 Integra LifeSciences Corporation: Key Developments

Table 30 Smith and Nephew: Overview

Table 31 Smith and Nephew: Product Portfolio

Table 32 Smith and Nephew: Key Developments

Table 33 Urgo Medical: Overview

Table 34 Urgo Medical: Product Portfolio

Table 35 Urgo Medical: Key Developments

Table 36 Paul Hartmann: Overview

Table 37 Paul Hartmann: Product Portfolio

Table 38 Paul Hartmann: Key Developments

Table 39 Bauerfeind Canada - Medical.: Overview

Table 40 Bauerfeind Canada - Medical.: Product Portfolio

Table 41 Bauerfeind Canada - Medical.: Key Developments

Table 42 Cardinal Health: Overview

Table 43 Cardinal Health: Product Portfolio

Table 44 Cardinal Health: Key Developments

Table 45 Medline: Overview

Table 46 Medline: Product Portfolio

Table 47 Medline: Key Developments

Table 48 Essity: Overview

Table 49 Essity: Product Portfolio

Table 50 Essity: Key Developments

Table 51 Medi GmbH &amp; Co. KG: Overview

Table 52 Medi GmbH &amp; Co. KG: Product Portfolio

Table 53 Medi GmbH &amp; Co. KG: Key Developments

List of Figures

Figure 1 Global Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 2 Global Venous Leg Ulcers Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure 3 Global Venous Leg Ulcers Treatment Market Share, By Sales Channel, 2022 &amp; 2030 (%)

Figure 4 Global Venous Leg Ulcers Treatment Market Share, By Region, 2022 &amp; 2030 (%)

Figure 5 Global Venous Leg Ulcers Treatment Market Y-o-Y Growth, By Treatment Type, 2022-2030 (%)

Figure 6 Compression Therapy Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 7 Advanced Wound Dressings Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 8 Debridement Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 9 Medications Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 10 Others Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 11 Global Venous Leg Ulcers Treatment Market Y-o-Y Growth, By Sales Channel, 2022-2030 (%)

Figure 12 End User Sales Channel in Global Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 13 Distribution Channel Sales Channel in Global Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 14 Global Venous Leg Ulcers Treatment Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 15 North America Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 16 Asia-Pacific Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 17 Europe Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 18 South America Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 19 Middle East and Africa Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 20 North America Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 21 North America Venous Leg Ulcers Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure 22 North America Venous Leg Ulcers Treatment Market Share, By Sales Channel, 2022 &amp; 2030 (%)

Figure 23 North America Venous Leg Ulcers Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 24 South America Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 25 South America Venous Leg Ulcers Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure 26 South America Venous Leg Ulcers Treatment Market Share, By Sales Channel, 2022 &amp; 2030 (%)

Figure 27 South America Venous Leg Ulcers Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 28 Europe Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 29 Europe Venous Leg Ulcers Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure 30 Europe Venous Leg Ulcers Treatment Market Share, By Sales Channel, 2022 &amp; 2030 (%)

Figure 31 Europe Venous Leg Ulcers Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 32 Asia-Pacific Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 33 Asia-Pacific Venous Leg Ulcers Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure 34 Asia-Pacific Venous Leg Ulcers Treatment Market Share, By Sales Channel, 2022 &amp; 2030 (%)

Figure 35 Asia-Pacific Venous Leg Ulcers Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure 36 Middle East &amp; Africa Venous Leg Ulcers Treatment Market Value, 2021-2030 (US$ Million)

Figure 37 Middle East &amp; Africa Venous Leg Ulcers Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure 38 Middle East &amp; Africa Venous Leg Ulcers Treatment Market Share, By Sales Channel, 2022 &amp; 2030 (%)

Figure 39 3M: Financials

Figure 40 Integra LifeSciences Corporation: Financials

Figure 41 Smith and Nephew: Financials

Figure 42 Urgo Medical: Financials

Figure 43 Paul Hartmann: Financials

Figure 44 Bauerfeind Canada - Medical.: Financials

Figure 45 Cardinal Health: Financials

Figure 46 Medline: Financials

Figure 47 Essity: Financials

Figure 48 Medi GmbH &amp; Co. KG: Financials

Venous Leg Ulcers Treatment Market Size, Share, Growth, and Outlook (2024-2031)

Compression Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 December 09

Starting from

Wound Dressing Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 16

Starting from